Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport

被引:171
作者
Fog, Jacob U.
Khoshbouei, Habibeh
Holy, Marion
Owens, William A.
Vaegter, Christian Bjerggaard
Sen, Namita
Nikandrova, Yelyzaveta
Bowton, Erica
McMahon, Douglas G.
Colbran, Roger J.
Daws, Lynette C.
Sitte, Harald H.
Javitch, Jonathan A.
Galli, Aurelio
Gether, Ulrik [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Pharmacol, Ctr Pharmacogenom, DK-2200 Copenhagen, Denmark
[3] H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark
[4] Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Ctr Mol Neurosci, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA
[6] Med Univ Vienna, Inst Pharmacol, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria
[7] Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA
[8] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA
[9] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[10] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA
关键词
D O I
10.1016/j.neuron.2006.06.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Efflux of dopamine through the dopamine transporter (DAT) is critical for the psychostimulatory properties of amphetamines, but the underlying mechanism is unclear. Here we show that Ca2+/calmodulin-dependent protein kinase II (CaMKII) plays a key role in this efflux. CaMKII alpha bound to the distal C terminus of DAT and colocalized with DAT in dopaminergic neurons. CaMKII alpha stimulated dopamine efflux via DAT in response to amphetamine in heterologous cells and in dopaminergic neurons. CaMKII alpha phosphorylated serines in the distal N terminus of DAT in vitro, and mutation of these serines eliminated the stimulatory effects of CaMKII alpha. A mutation of the DAT C terminus impairing CaMKII alpha binding also impaired amphetamine-induced dopamine efflux. An in vivo role for CaMKII was supported by chronoamperometry measurements showing reduced amphetamine-induced dopamine efflux in response to the CaMKII inhibitor KN93. Our data suggest that CaMKII alpha binding to the DAT C terminus facilitates phosphorylation of the DAT N terminus and mediates amphetamine-induced dopamine efflux.
引用
收藏
页码:417 / 429
页数:13
相关论文
共 42 条
[1]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[2]   Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions [J].
Bjerggaard, C ;
Fog, JU ;
Hastrup, H ;
Madsen, K ;
Loland, CJ ;
Javitch, JA ;
Gether, U .
JOURNAL OF NEUROSCIENCE, 2004, 24 (31) :7024-7036
[3]   Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry [J].
Callaghan, PD ;
Irvine, RJ ;
Daws, LC .
NEUROCHEMISTRY INTERNATIONAL, 2005, 47 (05) :350-361
[4]   Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms [J].
Cervinski, MA ;
Foster, JD ;
Vaughan, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (49) :40442-40449
[5]   Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6 [J].
Chen, NH ;
Reith, MEA ;
Quick, MW .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :519-531
[6]   Targeting of calcium/calmodulin-dependent protein kinase II [J].
Colbran, RJ .
BIOCHEMICAL JOURNAL, 2004, 378 :1-16
[7]   Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat [J].
Daws, LC ;
Irivne, RJ ;
Callaghan, PD ;
Toop, NP ;
White, JM ;
Bochner, F .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) :955-977
[8]   Dendrodendritic inhibition through reversal of dopamine transport [J].
Falkenburger, BH ;
Barstow, KL ;
Mintz, IM .
SCIENCE, 2001, 293 (5539) :2465-2470
[9]  
FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203
[10]  
Galli A, 1997, J NEUROSCI, V17, P3401